Similarly, Luo et al. Have reported that GAS5 acts as a tumor suppressor in prostate cancer development and progression via interacting with E2F1 and elevating the binding of E2F1 to the P27Kip1 promoter [40]. Here, E2F1 is linked to prostate carcinoma.